Objective The pathologic validation of European Alzheimer's Disease Consortium
Alzheimer's Disease Neuroimaging Initiative Center Harmonized Hippocampal …

Hippocampal atrophy, amyloid plaques, and neurofibrillary tangles are established
pathologic markers of Alzheimer's disease. We analyzed the temporal lobes of 9 Alzheimer's …

Background Imaging techniques used to measure hippocampal atrophy are key to
understanding the clinical progression of Alzheimer's disease (AD). Various semi-automated …

Introduction: One pathological hallmark of Alzheimer's disease (AD) is atrophy of medial
temporal brain regions that can be visualized on magnetic resonance imaging (MRI), but not …

Background Structural MRI measures for monitoring Alzheimer's Disease (AD) progression
are becoming instrumental in the clinical practice, and more so in the context of longitudinal …

Abstract Background The European Alzheimer's Disease Consortium and Alzheimer's
Disease Neuroimaging Initiative (ADNI) Harmonized Protocol (HarP) is a Delphi definition of …

Abstract Objectives Hippocampal radiomic features (HRFs) can serve as biomarkers in
Alzheimer's disease (AD). However, how different hippocampal segmentation methods …

Hippocampal atrophy as assessed by magnetic resonance imaging (MRI) and abnormal
cerebrospinal fluid (CSF) biomarkers are supportive features for the diagnosis of Alzheimer's …

Purpose: To prospectively evaluate the accuracy of automated hippocampal volumetry to
help distinguish between patients with Alzheimer disease (AD), patients with mild cognitive …

Background: Histopathological studies and animal models suggest that hippocampal
subfields may be differently affected by aging, Alzheimer's disease (AD), and other diseases …